Navigation Links
OrbusNeich's Genous™ Bio-engineered R stent™ Shows Favorable Safety Profile and Clinical Outcomes in Combination with Paclitaxel-Coated Balloon for De Novo Coronary Artery Disease
Date:9/23/2010

WASHINGTON, Sept. 23 /PRNewswire/ -- OrbusNeich today announced that six-month follow-up clinical trial data demonstrate the excellent safety profile and efficacy of the company's Genous Bio-engineered R stent in combination with a paclitaxel-coated balloon for the treatment of de novo coronary artery disease. The data were presented by Jochen Woehrle, M.D., University of Ulm, Germany, principal investigator of the study, in the first report clinical trial session at Transcatheter Cardiovascular Therapeutics (TCT) 2010 in Washington.

The PERfECT STENT (A Prospective, Randomized Trial Evaluating a Paclitaxel-Eluting Balloon in Patients Treated with Endothelial Progenitor Cell Capturing Stents for De Novo Coronary Artery Disease) study compared the combination of a paclitaxel-coated balloon (SeQuent® Please, B. Braun) with a Genous stent to the Genous stent alone in 120 patients undergoing percutaneous coronary intervention (PCI).

The primary endpoint of the study was in-stent late loss at six months. Secondary endpoints included diameter stenosis, binary restenosis rate, target lesion revascularization (TLR), major adverse cardiac events (MACE) and stent thrombosis.

The in-stent late loss at six months follow-up of 0.34 mm was significantly lower in the patient group treated with the Genous stent in combination with a paclitaxel-coated balloon when compared to 0.88 mm in the control group. There was no definite and probable stent thrombosis reported in either arm of the study. Both patient groups received three months of dual antiplatelet therapy. In addition, the rates of TLR and MACE were lower in the investigational group compared to the control group.

"We are very encouraged by the good clinical and safety outcomes seen in patients treated with a combination of a paclitaxel-coated balloon and pro-healing technologies with only three months of dual antiplatelet therapy," said Professor Woehrle. "This study supports the company
'/>"/>

SOURCE OrbusNeich
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. 100 Percent Coverage of Struts and Complete Neointimal Coverage of OrbusNeichs Genous™ Bio-engineered R stent™ Demonstrated 26 Days Post-Implantation in STEMI Patient
2. Data Show OrbusNeichs Genous™ Bio-engineered R stent™ is Safe and Effective in Combination with Drug-Eluting Balloon
3. OrbusNeichs Genous(TM) Bio-engineered R stent(TM) Demonstrates Excellent Safety and Clinical Outcomes in High-Risk Elderly Patients
4. Data Presented at ACC/i2 Summit Demonstrate Impressive Long Term Clinical Outcomes in Real World Patients Treated with OrbusNeichs Genous(TM) Bio-engineered R stent(TM)
5. OrbusNeich Announces First Patient Enrolled in Randomized Clinical Trial of Genous(TM) Bio-engineered R stent(TM) in China
6. Clinical Data Presented at Asia PCR/Sing LIVE Demonstrate Benefits of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) in Challenging Patient Subsets
7. Pre-clinical Data Show OrbusNeichs Combo Bio-engineered Sirolimus Eluting Stent May Offer Advantages to Current Drug Eluting Stent Technologies
8. Data From Multiple Clinical Trials of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2009
9. Long Term Data Presented at EuroPCR 2009 from Randomized Study Attest to Durability of Results of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) Compared to Drug-Eluting Stents
10. Interim Analysis of 12-Month Data from e-HEALING Registry Shows Good Safety and Efficacy in Real-World Use of OrbusNeichs Genous(TM) Bio-engineered R stent(TM)
11. Data From Multiple Clinical Trials of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... and Markets has announced the addition of the "Hematology ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 The ... in developed countries; however, it is expected to witness high growth ... India , and Brazil in ... analyzers and reagents market is driven by factors such as increasing ...
(Date:7/30/2014)... Research and Markets has announced ... Packaging Industry Report 2014" report to their offering. ... The Global and Chinese Aseptic Packaging Industry Report is ... of the global Aseptic Packaging industry with a focus ... basic overview of the industry including definitions, classifications, applications ...
(Date:7/30/2014)... 2014   Unique Pizza and Subs Corporation ... UPZS), a Delaware Corporation, is pleased to announce ... Pharmaceutical Corporation ("Larasan"), a nature-based pharmaceutical company that produces ... US-based Larasan will work with Unique to help ... Larasan,s vast distribution network throughout China ...
Breaking Medicine Technology:Hematology Analyzers & Reagents Market - Forecasts to 2019 2Global and Chinese Aseptic Packaging Industry Report 2014 2Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 2Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 3
... COUNTY, Calif., Nov. 18, 2010 Beckman Coulter, Inc. ... and marketer of products that simplify, automate, and innovate ... Coulter,s senior vice president corporate strategy, will present at ... Care Conference on Wednesday, December 1, 2010 at 12:30pm ...
... Nov. 18, 2010 NeoStem, Inc. (NYSE Amex: ... with operations in the U.S. and China, today announced that ... at the 2010 Maxim Group Growth Conference this morning and ... events will be held in New York, NY. ...
Cached Medicine Technology:Beckman Coulter to Present at the Piper Jaffray 22nd Annual 'Unplugged' Health Care Conference 2NeoStem to Present at Two Investor Conferences Thursday, November 18, 2010 2NeoStem to Present at Two Investor Conferences Thursday, November 18, 2010 3
(Date:7/30/2014)... July 30, 2014 LTC Consumer, an independent, ... term care insurance, features an Instant Quote tool on its ... co-founder of LTC Consumer. Quotes are free and unlimited. , ... in only seven areas – including age, gender, and state ... within seconds (you don’t need to enter any contact information ...
(Date:7/30/2014)... Washington, DC (PRWEB) July 30, 2014 ... its appreciation to U.S. Sens. Thad Cochran (R-MS) ... push for improvements in telemedicine coverage under Medicare, ... Cochran and Wicker, both Mississippi Republicans, introduced the ... bill to a House version, H.R. 3306, introduced ...
(Date:7/30/2014)... Portland, OR (PRWEB) July 30, 2014 ... and evaluating the quality of care that their ... company’s CEO, Mr. Andrew Rowe, discussed the importance ... order to improve physician performance and quality of ... for effective practitioner evaluation, Mr. Rowe elaborated on ...
(Date:7/30/2014)... Bay Aquarium Research Institute (MBARI) have observed a deep-sea ... yearslonger than any other known animal. Throughout this time, ... from predators. This amazing feat represents an evolutionary balancing ... having plenty of time to develop within their eggs, ... little or no food. , Every few months for ...
(Date:7/30/2014)... 30, 2014 Frozen shoulder (Adhesive capsulitis) affects ... to develop this nasty condition which occurs most frequently in ... last up to two and half years if not treated. ... and with good reason: it can render your shoulder so ... is, if you aren't in too much pain to get ...
Breaking Medicine News(10 mins):Health News:LTC Consumer Launches Online Tool for Getting Instant Long Term Care Insurance Estimates 2Health News:ATA Applauds Senators’ Push for Federal Telemedicine Improvements 2Health News:AllMed Webinar Helps Hospitals Optimize Practitioner Evaluations in Peer Review 2Health News:AllMed Webinar Helps Hospitals Optimize Practitioner Evaluations in Peer Review 3Health News:Deep-sea octopus broods eggs for over 4 years -- longer than any known animal 2Health News:Deep-sea octopus broods eggs for over 4 years -- longer than any known animal 3Health News:Good News for Diabetics Suffering from Frozen Shoulder 2Health News:Good News for Diabetics Suffering from Frozen Shoulder 3Health News:Good News for Diabetics Suffering from Frozen Shoulder 4
... help unravel how diseases form, , , TUESDAY, Dec. 23 (HealthDay ... tissues may contribute to certain human traits, including how likely ... says. , Researchers at Duke University Medical Center found ... protein it tells cells to produce. Such variation can lead ...
... 16 states where Medicaid doesn,t fund procedure , , ... infants aren,t being circumcised each year, because their states ... , "There,s a good case to be made that ... A. Leibowitz, a professor of public policy at the ...
... radiation therapy to treat cancer inevitably involves exposure of ... been well established, a number of patients experience distressing ... side effects related to inflammatory process cause discomfort and ... time. , A research article to be published ...
... member,s stay, , , TUESDAY, Dec. 23 (HealthDay News) -- If a ... you can help cheer them up by bringing a bit of ... family and festivities, can be a bit unnerving and sad for ... Houston, said in a hospital news release. "Anytime you can bring ...
... Celebration at J Lounge in downtown Los Angeles, on Friday, December 26th ... the Blue Diamond Foundation, which was founded to assist people who need ... ... 2008 -- Boxer Manny Pacquiao, fresh off his victory against Oscar Dela ...
... already revolutionized the way people around the world communicate and ... are about to do the same thing for medicine. ... engineering professor Aydogan Ozcan, a prototype cell phone has been ... and malaria patients, as well as testing water quality in ...
Cached Medicine News:Health News:Genes Seem to Affect Tissues Differently 2Health News:Circumcision Rates Too Low 2Health News:What is the mechanism of the chronic radiation enteritis? 2Health News:Take the Holiday to the Hospital 2Health News:Pacquiao Hosts Post-Christmas/Post-Birthday Victory Celebration 2Health News:Cell phones using lens-free imaging promise to improve health monitoring 2
Angled 45 Degrees to Right, 9.5mm blade, gently curved .5x .25mm blunt tips; Lower blade is 0.5mm longer; 14mm from mid screw to tip; (Available in left and right;) overall length 120mm; Stainless ...
Angled 45 Degrees to Right, 9.5mm blade, gently curved .5x .25mm blunt tips; Lower blade is 0.5mm longer; 14mm from mid screw to tip; (Available in left and right; ) overall length 120mm; Stainless ...
0.12 1x2 tips on a 2.5mm platform; Stainless Steel Tip; 32mm shaft; Titanium Handle....
4 Gently Curved, Prongs, 5mm Extended, Stainless Steel Tip; with Titanium Handle....
Medicine Products: